A New Sterol Diglycoside from Conyza floribunda by Opiyo, SA et al.
A New Sterol Diglycoside from Conyza floribunda
Sylvia A. Opiyoa*, Joseph A. Ogura, Lawrence O.A. Manguroa, Lutz F. Tietzeb and Heiko Schusterb
aDepartment of Chemistry, Maseno University, P. O. Box 333, Maseno, Kenya.
bInstitute for Organic and Biomolecular Chemistry, Georg-August University, Tamannstrasse 2, 37007-Göttingen, Germany.
Received 7 November 2008, revised 24 July 2009, accepted 2 September 2009.
ABSTRACT
Chemical investigation of CH2Cl2 and MeOH extracts of Conyza floribunda have led to the isolation of (24S)-ethylcholesta-5, 22E,
25-trien-3-O-glucosyl (1” 4’)-rhamnoside (1), (24S)-ethylcholesta-5,25-dien-3-O--glucoside (2), cyasterone (3), stigmasta
5, 22-dien-3-acetate (4), stigmasta 5, 22-dien-3-ol (5), spinasta 7, 22-dien-3-ol (6), 3-oxofriedooleanane (7), 3-hydroxyfriedooleanane
(8), 3-acetoxyfriedooleanane (9), betullinic acid (10), quercetin 3-O--glucoside (11), quercetin (12), myricetin (13) and
kaempferol (14). Their structures were determined using spectroscopic and physical methods as well as comparison with data
available in the literature.
KEYWORDS
Conyza floribunda, asteraceae, triterpenes, sterols, flavonols.
1. Introduction
The genus Conyza (Asteraceae) comprises about fifty species,
which are mainly found in the tropical and subtropical regions.1,2
In Kenya, the genus is represented by twenty-four species,
distributed countrywide and one such plant is Conyza floribunda.
The plant grows up to 3 m tall when fully mature and is common
in wet regions along the road edges, gardens and in disturbed
soils at altitudes of 400–2000 m above sea level.3 It is traditionally
used for a variety of pharmacological applications including
treatment of smallpox, chickenpox, sore throat, ringworm and
other skin related diseases, toothache and to stop bleeding from
injuries.4 Previous phytochemical studies on the plant are scarce.
However, studies on other related species have led to the isolation
of secondary metabolites, some of which have been reported to
exhibit biological activities including anti-inflammatory,5–7
antitumour,8,9 anti-oxidant10,11 and antibacterial12 activities. In the
present study, CH2Cl2 and MeOH extracts of C. floribunda were
subjected to phytochemical investigation, leading to the isola-
tion of a new sterol glycoside (1). Together with it were known
compounds (2–14).13–15 This is the first phytochemical report on
C. floribunda and the presence of compounds 1–3 is of interest
because they have never been reported from any Conyza species.
The NMR and mass spectra of the known compounds were in
complete agreement with the published values and were deduced
in a completely independent way using 2D experiments includ-
ing COSY (homonuclear correlation spectroscopy) and gHSQC
(gradient heteronuclear single quantum correlation spectros-
copy), and 1D-TOCSY experiments with selective excitation.
2. Results and Discussion
Compound 1, a colourless amorphous powder, was shown to
have a molecular formula of C41H66O10 as determined by
13C NMR (41 distinct peaks) and DEPT, and the ESI-MS spectrum
showed quasimolecular ion peaks at m/z 741.7 [M+Na]+ and
763.8 [M+HCOO–]+, suggesting the molar mass of the compound
to be 718 g mol–1. The fragment ion peaks in the EIMS (70 eV)
spectrum at m/z 410 [M-C12H20O9]
+, 395 [M-C12H20O9-CH3]
+, 392
[M-C 1 2 H 2 0 O 9 -H 2 O]
+ , 381 [M-C 1 2 H 2 0 O 9 -C 2 H 5 ]
+ , 377
[M-C12H20O9-CH3-H2O]
+, 363, 314, 300 [M-C12H20O9 part of the
side chain]+, 271 [M-C12H20O9-C10H19-2H]
+, 255 [M-C12H20O9-
C10H19-H2O]
+, 213 [M-C12H20O9-H2O C10H19-part of ring D]
+ and




127, 74 and 57 obtained from the sugar moieties suggested that
compound 1 may be a diglycoside with a C29-sterol (m/z 410)
aglycone moiety.16 In fact, the fragmentation pattern observed
for the aglycone pointed out that 1 is a C29-sterol with three
double bonds, two in the C10 side chain and the other in the ring
skeleton.16 This was further supported by fragment ions at m/z
273, 231 and 213 which are typical of a ∆5-3β-hydroxy sterol
nucleus whereas the ions centered at m/z 326 and 310 are diag-
nostic of C-22 and C-25 unsaturated side chains of sterols.16 The
formation of the latter ions is probably due to electron impact
induced rearrangement of the ∆25 compound to its ∆24 isomer,
followed by a McLafferty rearrangement via a six- or seven-
membered cyclic transition state. The foregoing evidence was
supported by the 1H NMR olefinic proton signals at δ 4.88 and
4.81 ppm, typical of an exomethylene group (CH2-26). Similarly,
the presence of two olefinic protons at δ 5.21 (dd, J = 15.4, 7.7 Hz)
and 5.17 ppm (dd, J = 15.4, 7.8 Hz) conferred the configuration of
the double bond as E,18 a fact further supported by the IR peak at
963 cm–1 for a trans-disubstituted double bond.19
The configuration at C-24 was suggested to be 24S (24β) on the
basis of the 1H NMR chemical shifts and coupling constants,
which agreed well with those of (24S)-ethylcholesta-5,22,25-
triene-3 β-acetate.16 This was further supported by comparative
analysis of the 1H and 13C NMR signals of compound 1 side chain
chemical shifts and coupling constants with an authentic sample
(22E-stigma-4,22,25-trien-3-one) having confirmed 24β configu-
ration.19 The good compatibility of the side chains in terms of 1H
and 13C NMR chemical shifts and coupling constants for the two
compounds suggested that compound 1 also has 24β-ethyl
configuration, which is consistent with previous observation for
∆5,22,25 sterols.20
Acid hydrolysis of the compound afforded glucose and
rhamnose as the sugar residues, identified by TLC and PC
co-chromatography with authentic samples. This was further
supported by ESI-MS spectrum peaks at m/z 579.4 [M+Na-162]+
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and 433.3 [M+Na-162-146]+, which together with the character-
istic 1H NMR anomeric proton peaks at δ 4.75 (d, J = 1.2 Hz) and
4.46 ppm (d, J = 7.7 Hz) suggested that glucose was present as a
terminal sugar.21 The position of the glucosyl-rhamnosyl moiety
on the aglycone was established by gHMBC experiments (Fig. 1),
as was ascertained by the correlations between the peaks at
δ 4.75 ppm (H-1’) and δc 74.6 ppm (C-3). Similarly, a cross-peak
between H-1” of glucose (δ 4.46 ppm) with δc 82.3 ppm (C-4’) of
rhamnose indicated position C-4’ of rhamnose as the glycosidic
linkage site, thus confirming a glucosyl (1”→4’)-rhamnose moiety
as previously described for 3-O-substituted kaempferol deriva-
tives22 and triterpenoid saponins.21 Therefore, on the basis of
spectroscopic evidence, compound 1 was concluded to be
(24S)-ethylcholesta-5,22E,25-trien-3-O-glucosyl (1”→ 4’)-rham-
noside.
Compound 2 showed UV absorption at λmax 193.5 nm (log
ε 0.197), suggesting lack of conjugation, while the IR absorption
bands at νmax 3406, 1644 and 1198–1023 cm
–1 signified the presence
of hydroxyl, double bond and ether linkages, respectively.
The NMR data of the aglycone of compound 2 were similar to
those of clerosterol23 except for the presence of a sugar unit, as
evidenced by the doublet at δ 4.52 ppm (J = 7.5 Hz) representing
the anomeric proton. Acid hydrolysis of 2 yielded glucose as the
sugar residue, identified by TLC and PC co-chromatography
with authentic samples and the large coupling constant of the
anomeric proton indicated that the glucose unit was present in
the β-configuration. This was supported by the 13C NMR spec-
trum, which displayed a total of 35 carbons; their multiplicity as-
signments using DEPT established the presence of five methyls,
thirteen methylenes, thirteen methines and four quaternary
carbons. This, together with two quasimolecular peaks at m/z
619.4 [M+HCOO–]+ and 597.6 [M+Na]+ in the ESI-MS spectrum
suggested the molar mass to be 574 g mol–1. Further insight into
the structure of 2 was provided by close examination of both the
1H NMR and the EIMS spectral data. The fragments at m/z 412




+ and 163 [glc]+, together with 1H NMR
peaks at δ 5.32 (t, H-6), 4.73, 4.64 (br s × 2, H-26) and 3.46 ppm (m,
H-3) indicated that the compound is ∆5,25-sterol glucoside,18 with
a sugar linked to the aglycone at C-3, as was ascertained by
gHMBC correlation between C-1’ of glucose (δ 100.8 ppm) and
H-3 (δ 3.46 ppm). On the basis of spectroscopic data as well as
comparison with literature, compound 2 was concluded to be
24-ethylcholesta-5,25-diene-3-O-β-glucoside.
Compound 3, a colourless amorphous powder, exhibited
absorptions at λmax 194.5 and 239.0 nm in the UV spectrum. Its
IR νmax showed the presence of an OH group (3405 cm
–1), a
five-membered lactone ring (1741 cm–1) and a conjugated
carboxyl (1654 cm–1).24 The ESI-MS suggested a molar mass of
520 g mol–1, corresponding to the formula C29H44O6 due to
quasimolecular ion peaks at m/z 543.2 [M+Na]+ and 565.7
[M+HCOO–]+, respectively. The 1H NMR spectrum of the
compound afforded five methyl signals, of which three were
tertiary (δ 1.18, 0.96 and 0.84 ppm) and the remaining two were
secondary (δ 1.42 and 1.28 ppm, appearing as doublets). The
fully decoupled 13C NMR spectrum was consistent with a
tetracyclic ring system of the ecdysterioid type of compound25
and also further supported the presence of a five-membered
lactone ring as evidenced by characteristic peaks at δ 81.9 ppm
(C-28) and 181.7 ppm (C-26).24 The presence of a carbon signal at
δ 206.3 ppm suggested the presence of a conjugated carbonyl
group at C-6,26 a fact that was supported by the presence of
olefinic carbon atoms at δ 122.3 (C-7) and 167.6 ppm (C-8);
confirmed by the presence of a vinyl proton signal at δ 5.81 ppm
in the 1H NMR spectrum. In fact, the 1H and 13C NMR data closely
resembled cyasterone previously isolated from Ajuga reptans var.
Atropurpurca,25 and supported by the carbon signals at δ 85.3,
81.9, 77.8, 75.2, 68.7 and 68.5 ppm, indicating the presence of six
oxygenated carbon atoms, four of which were secondary and
were correlated to protons at δ 4.20, 3.93, 3.82 and 3.52 ppm in
the gHSQC spectrum of the compound. The structure of the
compound was concluded by critically evaluating both the NMR
(1H, 13C, DEPT and 2D NMR) and MS data and by comparing
with the published data on cyasterone, which were found to be
in complete agreement. Thus, based on spectroscopic data and
comparative analysis with the literature data, compound 3 was
concluded to be cyasterone.
3. Experimental
3.1. General Experimental Procedure
Melting points were determined on a Gallenkamp (Lough-
borough, UK) melting point apparatus and are uncorrected.
Distilled solvents were used for extraction and chromatographic
separations. The UV spectra were run on Pye Unicam SP8-150
UV/visible spectrophotometer (Cambridge, UK) using aceto-
nitrile. IR data were recorded on a Perkin-Elmer FTIR 600 series
spectrophotometer (Waltham, MA, USA). The NMR data were
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Figure 1 Key HMBC and NOESY correlations for compound 1.
measured in CDCl3 and CDCl3-DMSO-d6 on a Bruker NMR
ultrashield TM (Darmstadt, Germany) operating at 500 and
125 MHz, respectively. The MS data were obtained on a Varian
MAT 8200A instrument (Bremen, Germany). Preparative HPLC
was performed using LC apparatus (Darmstadt, Germany) con-
sisting of a L-6200 pump, an auto sampler spectral series AS 100,
a variable wavelength 100 UV-visible detector set at 211 nm and
a Hewlett-Packard integrator model HP 3396 A (Norwalk, CT,
USA). A hypersil BDS C-18 5 µm (100 × 4.0 mm i.d.) column was
used in the separation process and the mobile phase was
acetonitrile:H2O (35:65).
3.2. Plant Material
Authenticated Conyza floribunda whole plant was collected at
Maseno University botanic garden in June 2005 and a voucher
specimen deposited at the National Museum of Kenya (voucher
deposit number: 2005/06/01/SAO/CHEMMK). The whole plant
was air-dried in the open and reduced to a powder using a mill.
3.3. Extraction and Isolation of CH2Cl2 Extract
Powdered plant material (2 kg) was extracted with CH2Cl2 (3 L)
by percolation for one week with occasional shaking, thereafter
filtered and then concentrated in vacuo using a rotary evaporator
to afford 80 g of a dark green semi-solid material. Approximately
75 g of the extract was dissolved in a small amount of CH2Cl2 and
adsorbed onto silica gel for column chromatography. Fraction-
ation of the extract using gradient of n-hexane:ethyl acetate,
ethyl acetate and MeOH afforded 300 fractions (each 20 mL)
whose compositions were monitored by TLC using n-hexane:
EtOAc (9:1; 4:1 and 2:1) and CH2Cl2:MeOH (9:1 and 4:1) solvent
systems respectively. Those showing similar TLC profiles were
combined resulting in four pools (I–IV). Pool I (fractions 1–90,
15 g) was mainly composed of fats and waxes and was stored for
GC-MS analysis. Fractions 91–170 constituted pool II (25 g),
which was found to contain two major spots contaminated with
impurities and was further purified using medium pressure
chromatography, eluting with n-hexane:ethyl acetate (9:1 and
4:1) to give stigmasta-5,22-diene-3-acetate (4, 175 mg) and
3-acetoxyfriedooleanane (9, 95 mg). Pool III (fractions 171–250,
15 g) upon repeated fractionation using n-hexane:ethyl acetate
(4:1 and 3:1) yielded spinasta-7,22-diene-3-ol (6, 75 mg) contami-
nated with 5, 3-oxofriedooleanane (7, 55 mg) and 3-hydroxy-
friedooleanane (8, 165 mg). Pool IV (11 g) gave stigmasta-5,22-
dien-3-ol (5, 100 mg) and betulinic acid (10, 85 mg).
3.4. Extraction and Purification of MeOH Extract
The residue from CH2Cl2 extraction was further extracted with
MeOH (3 L) in the cold for seven days, filtered and the solvent
removed as usual using a rotary evaporator yielding a dark
green material (45 g). The extract was pre-adsorbed onto silica
gel and chromatographed with CH2Cl2:MeOH gradient to pure
MeOH affording 120 fractions of 50 mL each. The compositions
of the fractions were monitored by TLC using CH2Cl2:MeOH
eluents (4:1, 3:2 and 1:1) and those that exhibited similar TLC
profiles were combined to constitute three major pools (V–VII).
Fractions 10–50 (Pool V, 12 g) was further purified by chromatog-
raphy using CH2Cl2:MeOH (9:1) followed by the same solvent
system in the ratio 4:1 to give kaempferol (14, 85 mg), cyasterone
(3, 78 mg), quercetin (12, 105 mg) and 24-ethylcholesta-
5,25-dien-3-O-β-glucoside (2, 93 mg). Pool VI (fractions 51–80,
15 g) was similarly isolated with CH2Cl2:MeOH (4:1) followed by
3:2 to afford myricetin (13, 55 mg) and quercetin 3-O-β-glucoside
(11, 105 mg). The remaining fractions (300 mg dissolved in a
minimum amount of acetonitrile) contained mainly compound
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1 contaminated with impurities, which could not be obtained in
pure form and was purified by preparative HPLC using
acetonitrile:H2O (35:65): mobile flow rate 10 mL min
–1 and inject-
ing 10 µL each time to afford 45 mg of pure compound.
(24S)-Ethylcholesta-5,22E,25-trien-3-O-glucosyl (1‘’ 4‘)-
rhamnoside (1)
Colourless amorphous powder from CH2Cl2:MeOH (9:1),
m.p. > 250 °C; [α]D
25 +35 ° (MeOH, c 0.2); UV λmax (CH3CN)
201 nm; IR νmax (KBr): 3550–3300 (OH), 3085 (=C-H), 2940, 2860
(C-H), 1640 (C=C), 1475, 1380, 1170, 1110, 1060, 1025, 963
(trans-disubstituted C=C), 810 (trisubstituted C=C), 720 cm–1;
1H NMR (CDCl3+drop DMSO-d6, 500 MHz): δH aglycone 5.34
(1H, d, J 5.5 Hz, H-6), 5.21 (1H, dd, J 15.4 and 7.7 Hz, H-22), 5.17
(1H, dd, J 15.4 and 7.8 Hz, H-23), 4.48 (1H, d, J 2.4 Hz, H-26a), 4.81
(1H,d, J 1.4 Hz, H-26b), 3.52 (1H, m, H-3), 2.52 (2H, m, CH2-4), 2.40
(1H, m, H-12a), 2.20 (1H, m, H-24), 2.18 (1H, m, H-12b), 1.97 (1H,
m, H-1b), 1.96 (1H, m, H-2b), 1.86 (1H, m, H-7b), 1.66 (3H, s,
CH3-27), 1.63 (1H, m, H-8), 1.56 (1H, m, H-15a), 1.52 (1H, m,
H-11b), 1.46 (1H, m, H-1a), 1.41 (1H, m, H-2a), 1.34 (1H, m, H-20),
1.32 (2H, m, CH2-16), 1.30 (1H, m, H-11a), 1.26 (1H, m, H-17), 1.25
(2H, m, CH2-28), 1.20 (1H, m, H-15b), 1.08 (1H, m, H-14), 1.07 (1H,
m, H-7a), 0.97 (3H, s, CH3-19), 0.96 (1H, m, H-9), 0.85 (3H, t,
CH3-29), 0.70 ppm (3H, s, CH3-18), rhamnose 4.75 (1H, d, J 1.2 Hz,
H-1’), 3.64 (1H, m, H-3’), 3.38 (1H, br s, H-2’), 3.34 (1H, m, H-5’),
3.30 (1H, t, J 9.7 Hz, H-4’), 0.96 ppm (3H, d, J 6.4 Hz, CH3-6’),
glucose 4.46 (1H, d, J 7.7 Hz, H-1”), 3.67 (1H, dd, J 11.7 and 3.5 Hz,
H-6b‘’), 3.56 (1H, dd, J 9.6 and 2.4 Hz, H-4”), 3.46 (1H, m, H-5”),
3.41 (1H, dd, J 11.7 and 5.4 Hz, H-6a‘’), 3.37 (1H, t, J 8.8 Hz, H-3”),
3.26 ppm (1H, t, 8.4 Hz, H-2”); 13C NMR (CDCl3+DMSO-d6): δc
aglycone 147.8 (C-25), 141.7 (C-5), 138.7 (C-22), 129.9 (C-23), 122.0
(C-6), 110.2 (C-26), 74.6 (C-3), 56.9 (C-14), 56.3 (C-17), 52.2 (C-24),
51.0 (C-9), 43.2 (C-13), 42.1 (C-4), 41.4 (C-20), 39.9 (C-12), 38.4
(C-1), 37.0 (C-10), 32.6 (C-8), 31.3 (C-7), 29.9 (C-2), 28.9 (C-16), 26.3
(C-28), 25.1 (C-15), 22.4 (C-21), 21.7 (C-11), 19.8 (C-27), 19.6 (C-19),
13.5 (C-29), 13.2 ppm (C-18), rhamnose 102.3 (C-1’), 82.3 (C-4’),
71.1 (C-5’), 70.5 (C-3’), 69.4 (C-2’), 17.8 ppm (C-6’), glucose 99.8
(C-1”), 78.1 (C-5”), 77.5 (C-3”), 74.4 (C-2”), 70.0 (C-4”), 62.2 ppm
(C-6”); EIMS (injection probe, 70 eV) m/z: 410 [M-C12H20O9]
+ (3),
395 [M-C12H20O9-CH3]
+ (11), 392 [M-C12H20O9-H2O]
+ (50), 381
[M-C12H20O9-C2H5]
+ (5), 377 [M-C12H20O9-CH3-H2O]
+ (7), 363 (9),
314 (3), 309 [C12H20O9]
+ (3), 300 [M-C12H20O9-part of side chain]
+
(6) , 282 (6) , 271 [M-C 1 2 H 2 0 O 9 -C 1 0 H 1 9 -2H]
+ (14) , 255
[M-C12H20O9-C10H19-H2O]
+ (45), 228 (60), 213 [M-C12H20O9-H2O-
C10H19-part of ring D]
+ (100), 163 [C6H11O5]
+ (13), 146 [C6H10O4]
+
(3), 127, (23), 74 (51), 57 (85 %); ESI-MS m/z: 763.8 [M+HCOO-]+
(negative ion mode); 741.7 [M+Na]+ (positive ion mode), 579.4
[M+Na-162]+, 433.8 [M+ Na-162-146]+, HRMS: m/z 741.2644
(C41H66O10Na, requires m/z 741.2637).
(24S)-Ethylcholesta-5,25-trien-3-O- -glucoside (2)
Colourless amorphous powder from CH2Cl2:EtOAc (1:1), m.p.
> 250 °C; [α]D
25 –46 ° (MeOH, c 0.5); UV λmax (CH3CN) 193.5 nm
(log ε 0.197); IR νmax (KBr): 3406 (OH), 3072 (=C-H), 2960, 2884
(C-H), 1644 (C=C), 1455, 1372, 1198–1023 cm–1 (glycosidic link-
age); 1H NMR (CDCl3+drop DMSO-d6, 500 MHz): δ aglycone
5.32 (1H, t, J 3.6 Hz, H-6), 4.73 (1H, br s, H-26a), 4.64 (1H, br s,
H-26b), 3.46 (1H, m, H-3), 2.48 (2H, m, CH2-4), 2.34 (1H, m, H-12a),
2.12 (1H, m, H-12b), 1.93 (1H, m, H-1b), 1.92 (1H, m, H-2b), 1.82 (1H,
m, H-7b), 1.80 (2H, m, H-22 b and H-24), 1.61 (3H, s, CH3-27), 1.54
(1H, m, H-15a), 1.50 (1H, m, H-8), 1.46 (1H, m, H-11b), 1.51 (1H, m,
H-1a), 1.38 (1H, m, H-20), 1.36 (1H, m, H-2a), 1.28 (2H, m, CH2-28),
1.24 (2H, m, H-16 and H-23a), 1.22 (1H, m, H-15b), 1.20 (1H, m,
H-17), 1.02 (2H, m, H-14 and H-22a), 1.00 (2H, m, H-7a and H-11a),
0.96 (3H, s, CH3-19), 0.94 (1H, m, H-9), 0.92 (1H, m, H-23b), 0.88
(3H, d, J 6.6 Hz, CH3-21), 0.78 (3H, t, J 7.2 Hz, CH3-29), 0.65 ppm
(3H, s, CH3-18), glucose 4.52 (1H, d, J 7.5 Hz, H-1’), 3.65 (1H, dd,
J 10.2 and 5.4 Hz, H-6b‘), 3.46 (1H, m, H-6’), 3.14 (1H, m, H-5’), 3.11
(1H, m, H-4’), 3.05 (1H, m, H-3’), 2.92 ppm (1H, m, H-2’); 13C NMR
(CDCl3+DMSO-d6): δc aglycone 146.8 (C-25), 140.4 (C-5), 121.1
(C-6), 111.4 (C-26), 71.9 (C-3), 56.1 (C-14), 55.4 (C-17), 49.6 (C-9),
48.7 (C-24), 41.8 (C-13), 40.3 (C-4), 38.7 (C-1), 38.3 (C-12), 36.1
(C-10), 34.8 (C-22), 34.7 (C-20), 33.1 (C-23), 31.4 (C-8), 31.3 (C-2),
29.3 (C-7), 28.6 (C-16), 25.9 (C-28), 24.7 (C-15), 20.5 (C-11), 18.9
(C-19), 17.6 (C-27), 12.8 (C-29), 11.6 ppm (C-18), glucose 100.8
(C-1’), 76.7 (C-5’), 76.6 (C-3’), 73.4 (C-2’), 70.1 (C-4’), 61.1 ppm
(C-6’); EIMS (injection probe, 70 eV) m/z: 412 [M-C6H10O5]
+ (8),
397 [M-C6H10O5-CH3]
+ (21), 394 [M-C6H10O5-H2O]
+ (25), 379
[M-C6H10O5-CH3-H2O]
+ (33), 363 (9), 314 (20), 299 (7), 273 (41),
255 (66), 231 (19), 229 (45), 213 (100 %); ESI-MS m/z: 619.4
[M+HCOO–]+ (negative ion mode); 597.6 [M+Na]+ (positive ion
mode).
Cyasterone (3)
Colourless amorphous powder from n-hexane:EtOAc (3:2);
m.p. 195–196 °C; UV λmax (CH3CN) 194.5 and 239.0 nm; IR νmax
(KBr): 3405 (OH), 1741 (lactone), 1654 (conjugated carbonyl),
1640, 1048 cm–1; 1H NMR (CDCl3, 500 MHz): δ 5.81 (1H, t, J 2.1 Hz,
H-7), 4.20 (1H, m, H-28), 3.93 (1H, d, J 15.0 Hz, H-3), 3.82 (1H, m,
H-2), 3.52 (1H, d, J 20.5 Hz, H-22), 3.28 (1H, d, J 23.0 Hz, H-5), 3.14
(1H, m, H-9), 2.49 (1H, dq, J 11.4, 6.9 Hz, H-25), 2.40 (1H, t, 8.4 Hz,
H-17), 2.32 (1H, m, H-24), 1.98 (2H, H-11a and H-15b), 1.90 (1H, m,
H-12b), 1.78 (1H, m, H-1b), 1.74 (2H, m, CH2-4), 1.72 (1H, m, H-11b),
1.61 (1H, m, H-15a), 1.56 (1H, m, H-23b), 1.45 (1H, m, H-23a), 1.42
(3H, d, CH3-29), 1.41 (1H, m, H-1a), 1.29 (2H, m, CH2-16), 1.28 (3H,
d, J 6.5 Hz, CH3-27), 1.18 (3H, s, CH3-21), 0.96 (3H, s, CH3-18), 0.87
(3H, s, CH3-19), 0.84 ppm (1H, m, H-12a);
13C NMR (CDCl3):
δ 206.3 (C-6), 181.7 (C-26), 167.6 (C-8), 122.3 (C-7), 85.3 (C-14), 81.9
(C-28), 77.8 (C-20), 75.2 (C- 22), 68.7 (C-2), 68.5 (C-3), 51.8 (C-5),
50.5 (C-17), 50.0 (C-24), 48.8 (C-13), 43.5 (C-25), 39.4 (C-10), 37.5
(C-1), 35.2 (C-9), 34.9 (C-23), 32.6 (C-11), 31.9 (C-15), 30.7 (C-16),
24.5 (C-19), 21.6 (C-11), 20.6 (C-21), 19.7 (C-29), 18.0 (C-18),
15.8 ppm (C-27); ESI-MS m/z: 565.7 [M+HCOO–]+ (negative ion
mode); 543.2 [M+Na]+ (positive ion mode).
Acid Hydrolysis
Compounds 1 and 2, each 15 mg in a mixture of 8 % HCl (2 mL)
and MeOH were separately refluxed for 2 h. The reaction mix-
tures were reduced in vacuo to dryness, dissolved in H2O (1 mL)
and neutralized with NaOH. The neutralized products were
subjected to TLC analysis (eluent EtOAc:MeOH:H2O:HOAc,
6:2:1:1) and PC (eluent n-BuOH:HOAc:H2O, 4:5:1 and
C6H6:n-BuOH:H2O:pyridine, 1:5:3:3). The chromatograms were
sprayed with aniline hydrogen phthalate followed by heating.
The sugars were identified after operating with authentic
samples.
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